BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 9619205)

  • 1. Olanzapine.
    Hale AS
    Br J Hosp Med; 1997 Nov 5-18; 58(9):442-5. PubMed ID: 9619205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine: an atypical antipsychotic for schizophrenia.
    Lund BC; Perry PJ
    Expert Opin Pharmacother; 2000 Jan; 1(2):305-23. PubMed ID: 11249551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral pharmacology of olanzapine: a novel antipsychotic drug.
    Moore NA; Leander JD; Benvenga MJ; Gleason SD; Shannon H
    J Clin Psychiatry; 1997; 58 Suppl 10():37-44. PubMed ID: 9265915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine: a novel atypical neuroleptic agent.
    Reus VI
    Lancet; 1997 May; 349(9061):1264-5. PubMed ID: 9142055
    [No Abstract]   [Full Text] [Related]  

  • 5. Olanzapine: a new antipsychotic agent with efficacy in the management of schizophrenia.
    Kando JC; Shepski JC; Satterlee W; Patel JK; Reams SG; Green AI
    Ann Pharmacother; 1997 Nov; 31(11):1325-34. PubMed ID: 9391688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses.
    Fulton B; Goa KL
    Drugs; 1997 Feb; 53(2):281-98. PubMed ID: 9028746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of olanzapine].
    Yui K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Jul; 19(3):101-10. PubMed ID: 10495984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical neuroleptics in child and adolescent psychiatry.
    Remschmidt H; Hennighausen K; Clement HW; Heiser P; Schulz E
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I9-19. PubMed ID: 11140784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic malignant syndrome after addition of haloperidol to atypical antipsychotic.
    Mujica R; Weiden P
    Am J Psychiatry; 2001 Apr; 158(4):650-1. PubMed ID: 11282706
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of olanzapine for elderly patients with psychotic disorders: a review.
    Madhusoodanan S; Sinha S; Brenner R; Gupta S; Bogunovic O
    Ann Clin Psychiatry; 2001 Dec; 13(4):201-13. PubMed ID: 11958362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse events related to olanzapine.
    Conley RR; Meltzer HY
    J Clin Psychiatry; 2000; 61 Suppl 8():26-9; discussion 30. PubMed ID: 10811240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine: efficacy in treating the positive and negative symptoms of schizophrenia.
    Gray R
    Ment Health Care; 1998 Feb; 1(6):193-4. PubMed ID: 9791411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine.
    Allan ER; Sison CE; Alpert M; Connolly B; Crichton J
    Psychopharmacol Bull; 1998; 34(1):71-4. PubMed ID: 9564201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosing the antipsychotic medication olanzapine.
    Nemeroff CB
    J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.
    Martín J; Gómez JC; García-Bernardo E; Cuesta M; Alvarez E; Gurpegui M
    J Clin Psychiatry; 1997 Nov; 58(11):479-83. PubMed ID: 9413413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel antipsychotics: comparison of weight gain liabilities.
    Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
    J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe akathisia during olanzapine treatment of acute schizophrenia.
    Jauss M; Schröder J; Pantel J; Bachmann S; Gerdsen I; Mundt C
    Pharmacopsychiatry; 1998 Jul; 31(4):146-8. PubMed ID: 9754850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atypical neuroleptics in child- and adolescent psychiatry].
    Remschmidt H; Hennighausen K; Clement HW; Heiser P; Schulz E
    Z Kinder Jugendpsychiatr Psychother; 2000 Feb; 28(1):45-57. PubMed ID: 10746298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine: keep an eye on this neuroleptic.
    Leblanc G
    Can Fam Physician; 2000 Aug; 46():1565-6, 1569. PubMed ID: 10955171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.